Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 451 AL 465

Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies

Salahuddin P, Khan RH, Furkan M, Uversky VN, Islam Z, Fatima MT.

Int J Biol Macromol. 2021 Sep 1;186:580-590. doi: 10.1016/j.ijbiomac.2021.07.056. Epub 2021 Jul 14.

The neurogenic niche in Alzheimer's disease

Wander CM, Song J.

Neurosci Lett. 2021 Sep 25;762:136109. doi: 10.1016/j.neulet.2021.136109. Epub 2021 Jul 13.

Efficacy and safety of pharmacotherapy for Alzheimer's disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials

Seibert M, Mühlbauer V, Holbrook J, Voigt-Radloff S, Brefka S, Dallmeier D, Denkinger M, Schönfeldt-Lecuona C, Klöppel S, von Arnim CAF.

Alzheimers Res Ther. 2021 Jul 16;13(1):131. doi: 10.1186/s13195-021-00867-8.

Influential role of 7-Ketocholesterol in the progression of Alzheimer's disease

Mahalakshmi K, Parimalanandhini D, Sangeetha R, Livya Catherene M, Beulaja M, Thiagarajan R, Arumugam M, Janarthanan S, Manikandan R.

Prostaglandins Other Lipid Mediat. 2021 Oct;156:106582. doi: 10.1016/j.prostaglandins.2021.106582. Epub 2021 Jul 14.

Bilingual problem-solving training for caregivers of adults with dementia: A randomized, factorial-design protocol for the CaDeS trial

Juengst S, Supnet C, Kew CLN, Silva V, Vega M, Han G, Kelley B, Smith ML, Maestre G.

Contemp Clin Trials. 2021 Sep;108:106506. doi: 10.1016/j.cct.2021.106506. Epub 2021 Jul 15.

Recent advances in drug repurposing using machine learning

Urbina F, Puhl AC, Ekins S.

Curr Opin Chem Biol. 2021 Dec;65:74-84. doi: 10.1016/j.cbpa.2021.06.001. Epub 2021 Jul 16.

APOE Genotype and Alzheimer's Disease: The Influence of Lifestyle and Environmental Factors

Angelopoulou E, Paudel YN, Papageorgiou SG, Piperi C.

ACS Chem Neurosci. 2021 Aug 4;12(15):2749-2764. doi: 10.1021/acschemneuro.1c00295. Epub 2021 Jul 18.

Photothermal and Photodynamic Therapies via NIR-Activated Nanoagents in Combating Alzheimer's Disease

Zeng F, Peng K, Han L, Yang J.

ACS Biomater Sci Eng. 2021 Aug 9;7(8):3573-3585. doi: 10.1021/acsbiomaterials.1c00605. Epub 2021 Jul 19.

Real-world Utilisation of the Rivastigmine Transdermal Patches Accompanying the Use of Risk Minimisation Tools in Patients with Dementia

Reinhardt F, Scarmeas N, Karan R, Veldandi UK, Modali S, Duvvuri K, Pathan RK.

Curr Alzheimer Res. 2021;18(4):273-282. doi: 10.2174/1567205018666210716120540.

Effects of Spices (Saffron, Rosemary, Cinnamon, Turmeric and Ginger) in Alzheimer's Disease

Seibel R, Schneider RH, Gottlieb MGV.

Curr Alzheimer Res. 2021;18(4):347-357. doi: 10.2174/1567205018666210716122034.

Defective Autophagy and Mitophagy in Alzheimer's Disease: Mechanisms and Translational Implications

Chen J, He HJ, Ye Q, Feng F, Wang WW, Gu Y, Han R, Xie C.

Mol Neurobiol. 2021 Oct;58(10):5289-5302. doi: 10.1007/s12035-021-02487-7. Epub 2021 Jul 19.

Epileptic Mechanisms Shared by Alzheimer's Disease: Viewed via the Unique Lens of Genetic Epilepsy

Kang JQ.

Int J Mol Sci. 2021 Jul 1;22(13):7133. doi: 10.3390/ijms22137133.

Does oxidatively damaged DNA drive amyloid-β generation in Alzheimer's disease? A hypothesis

Sanders OD, Rajagopal L, Rajagopal JA.

J Neurogenet. 2021 Sep-Dec;35(4):351-357. doi: 10.1080/01677063.2021.1954641. Epub 2021 Jul 20.

Resting-state EEG alpha/theta power ratio discriminates early-onset Alzheimer's disease from healthy controls

Özbek Y, Fide E, Yener GG.

Clin Neurophysiol. 2021 Sep;132(9):2019-2031. doi: 10.1016/j.clinph.2021.05.012. Epub 2021 Jun 6.

Aducanumab for Alzheimer's disease - too many unanswered questions

Phizackerley D.

Drug Ther Bull. 2021 Sep;59(9):130. doi: 10.1136/dtb.2021.000043. Epub 2021 Jul 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias